Abstract
Recent advances have shown that cell surface receptors are expressed differentially in normal and pathological conditions. Novel organ specific and disease specific proteins expressed on tumor vasculature have been identified by in vivo phage display technology and the diversity of the tumor-associated vasculature has provided the basis for the development of targeted therapeutics. Investigators recently screened a phage display library in a human cancer patient. An IL-11 mimic phage displaying the cyclic peptide CGRRAGGSC (single letter amino acid code) specifically bound to immobilized IL-11Rα. It has been demonstrated that the expression of the IL-11Rα is increased in several other types of tumors including osteosarcoma. The ability to selectively target the IL-11Rα may provide an alternative treatment of for a disease where new treatment options are truly needed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pasqualini R, Ruoslahti E (1996) Organ targeting in vivo using phage display peptide libraries. Nature 380:364–366
Pasqualini R, Arap W (2004) Hybridoma-free generation of monoclonal antibodies. Proc Natl Acad Sci U S A 101:257–259
Marchio S, Lahdenranta J, Schlingemann RO, Valdembri D, Wesseling P, Arap MA et al (2004) Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 5:151–162
Arap W, Kolonin MG, Trepel M, Lahdenranta J, Cardo-Vila M, Giordano RJ et al (2002) Steps toward mapping the human vasculature by phage display. Nat Med 8:121–127
Kiessling S, Muller-Newen G, Leeb SN, Hausmann M, Rath HC, Strater J et al (2004) Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells. J Biol Chem 279:10304–10315
Schwertschlag US, Trepicchio WL, Dykstra KH, Keith JC, Turner KJ, Dorner AJ (1999) Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. Leukemia 13:1307–1315
Teramura M, Kobayashi S, Yoshinaga K, Iwabe K, Mizoguchi H (1996) Effect of interleukin 11 on normal and pathological thrombopoiesis. Cancer Chemother Pharmacol 38(Suppl):S99–S102
Zurita AJ, Troncoso P, Cardo-Vila M, Logothetis CJ, Pasqualini R, Arap W (2004) Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 64:435–439
Hanavadi S, Martin TA, Watkins G, Mansel RE, Jiang WG (2006) Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer. Ann Surg Oncol 13:802–808
Nakayama T, Yoshizaki A, Izumida S, Suehiro T, Miura S, Uemura T et al (2007) Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int J Oncol 30:825–833
Lewis VO, Ozawa MG, Deavers MT, Wang G, Shintani T, Arap W et al (2009) The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res 69:1995–1999
Huang G, Yu L, Cooper LJ, Hollomon M, Huls H, Kleinerman ES (2012) Genetically modified T cells targeting interleukin-11 receptor alpha-chain kill human osteosarcoma cells and induce the regression of established osteosarcoma lung metastases. Cancer Res 72:271–281
Putoczki T, Ernst M (2010) More than a sidekick: the IL-6 family cytokine IL-11 links inflammation to cancer. J Leukoc Biol 88:1109–1117
Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C et al (2003) A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3:537–549
Kleinerman ES, Gano JB, Johnston DA, Benjamin RS, Jaffe N (1995) Efficacy of liposomal muramyl tripeptide (CGP 19835A) in the treatment of relapsed osteosarcoma. Am J Clin Oncol 18:93–99
Meyers PA, Schwartz CL, Krailo MD, Healey JH, Bernstein ML, Betcher D et al (2008) Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival – a report from the Children’s Oncology Group. J Clin Oncol 26:633–638
Moore C, Eslin D, Levy A, Roberson J, Giusti V, Sutphin R (2010) Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma. Pediatr Blood Cancer 55:1096–1102
Levine BL, Bernstein WB, Aronson NE, Schlienger K, Cotte J, Perfetto S et al (2002) Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat Med 8:47–53
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lewis, V.O. (2014). IL-11Rα: A Novel Target for the Treatment of Osteosarcoma. In: Kleinerman, M.D., E. (eds) Current Advances in Osteosarcoma. Advances in Experimental Medicine and Biology, vol 804. Springer, Cham. https://doi.org/10.1007/978-3-319-04843-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-04843-7_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-04842-0
Online ISBN: 978-3-319-04843-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)